Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020.
Naleway AL, Kim SS, Flannery B, Levine MZ, Murthy K, Sambhara S, Gangappa S, Edwards LJ, Ball S, Grant L, Zunie T, Cao W, Gross FL, Groom H, Fry AM, Hunt D, Jeddy Z, Mishina M, Wesley MG, Spencer S, Thompson MG, Gaglani M, Dawood FS.
Naleway AL, et al. Among authors: sambhara s.
Open Forum Infect Dis. 2023 Apr 21;10(6):ofad223. doi: 10.1093/ofid/ofad223. eCollection 2023 Jun.
Open Forum Infect Dis. 2023.
PMID: 37305842
Free PMC article.